selinexor
Selected indexed studies
- Selinexor. (, 2012) [PMID:37184196]
- Selinexor. (, 2006) [PMID:31369222]
- Selinexor in multiple myeloma. (Expert Opin Pharmacother, 2024) [PMID:38503547]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Selinexor-Bortezomib-Dexamethasone: A Review in Previously Treated Multiple Myeloma. (2023) pubmed
- Selinexor. (2012) pubmed
- Selinexor. (2006) pubmed
- Selinexor in multiple myeloma. (2024) pubmed
- Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial. (2020) pubmed
- Selinexor: First Global Approval. (2019) pubmed
- Selinexor in acute myeloid leukemia: therapeutic applications and current challenges. (2025) pubmed
- Selinexor in relapsed/refractory multiple myeloma. (2020) pubmed
- Selinexor's Immunomodulatory Impact in Advancing Multiple Myeloma Treatment. (2025) pubmed
- Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma. (2019) pubmed